Efficacy of ipragliflozin as monotherapy or as add-on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics
2017 ◽
Vol 9
(2)
◽
pp. 341-353
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):